Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 1, 2000Genes & DevelopmentOpen Access

Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP

View Full Paper
Ask AI
Bookmark
Share

Authors

AKAndrew L. KungBroad InstituteVRVivienne I. RebelBC Cancer AgencyRoderick T. BronsonRoderick T. BronsonBroad Institute

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kung et al. (2000) studied this question.

synapsesocial.com/papers/6a6f1aa4660549caf2c3a623https://doi.org/10.1101/gad.14.3.272
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Adenovirus E1A-associated 300-kD Protein Exhibits Properties of a Transcriptional Coactivator and Belongs to an Evolutionarily Conserved Family1994 · 46 citations
  2. 2The Morphology, Immunohistochemistry, and Incidence of Hematopoietic Neoplasms in Mice and Rats1993 · 91 citations
  3. 3Essential Role for the P55 Tumor Necrosis Factor Receptor in Regulating Hematopoiesis at a Stem Cell Level1999 · 90 citations
  4. 4Tumors in Rubinstein‐Taybi syndrome1995 · 289 citations
  5. 5Definition of adenovirus type 5 functions involved in the induction of chromosomal aberrations in human cells1990 · 31 citations